I'm sorry to say it, but Nexavar's rise is directly correlated with PI-88's fall. And for good reason.Nexavar is approved, has better clinical efficacy, and is orally delivered. Nexavar three, PI-88 zero.
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025